Florida Pancreas Collaborative Next Generation Biobank

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

August 6, 2022

Study Completion Date

June 11, 2026

Conditions
Pancreatic CancerCancer Cachexia
Interventions
OTHER

Blood Sample Collection

Participants will be asked to donate blood at baseline (+/- 30 days of diagnosis date) and at the time of follow-up (approximately 6 months and approximately 12 months after baseline).

OTHER

Tumor Sample collection

At the time of tissue biopsy and surgical resection (if applicable), pancreatic tumor tissue and tissue from site of metastasis will be collected.

OTHER

Data Collection

Participants will be asked to complete a 3 page screening tool at the time of their in-person clinic visit, as well as questionnaires at baseline and at 6 and 12 months.

Trial Locations (14)

32209

University of Florida - Jacksonville, Jacksonville

32308

Tallahassee Memorial Healthcare, Tallahassee

32804

Advent Health - Orlando, Orlando

32806

University of Florida - Orlando, Orlando

33016

Palmetto General Hospital, Hialeah

33136

Sylvester Comprehensive Cancer Center & Jackson Memorial Hospital, Miami

33140

Mount Sinai Medical Center, Miami Beach

33606

University of South Florida/Tampa General Hospital, Tampa

33612

H Lee Moffitt Cancer Center and Research Institute, Tampa

33705

St Anthony's Baycare/Bay Surgical Specialists, St. Petersburg

33805

Lakeland Regional Health, Lakeland

33905

Lee Memorial Hospital Regional Cancer Center, Fort Myers

34239

Sarasota Memorial Hospital, Sarasota

32610-0109

University of Florida - Gainesville, Gainesville

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT03851133 - Florida Pancreas Collaborative Next Generation Biobank | Biotech Hunter | Biotech Hunter